The battle against rectal cancer has entered an extraordinary new phase with the advent of immunotherapy, offering hope to ...

Plasmodium Immunotherapy is under clinical development by CAS-Lamvac Biotech and currently in Phase II for Colorectal Cancer.

Jimmy Carter’s 2015 melanoma diagnosis introduced the world to immunotherapy, sparking future cancer research. Millions of ...

The following is a summary of “Neoadjuvant Pembrolizumab in Stage I-III Deficient Mismatch Repair Colon Cancer: A Clinical ...

The immune system plays a pivotal role in colorectal cancer (CRC), with immune cells such as T cells, natural killer (NK) cells, macrophages, and dendritic ...

This is consistent with previous studies that have shown that treatment of irAEs does not affect tumour response.8 25 The impact of duration of immunotherapy on specific irAEs is less well defined, as ...

The Company believes IMC-R117C is the first PIWIL1-targeted immunotherapy and estimates that there are up to 20,000 colorectal cancer patients globally that are positive for both PIWIL1 and ...

The Company believes IMC-R117C is the first PIWIL1-targeted immunotherapy and estimates that there are up to 20,000 colorectal cancer patients globally that are positive for both PIWIL1 and HLA-A* ...

Colorectal cancer cases are increasing, especially among young adults under 55, with lifestyle and environmental factors possibly playing a role. While changes in bowel habits, including pencil ...